| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |